NCT01896180View on ClinicalTrials.gov

Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost

PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Primary Open Angle GlaucomaOcular HypertensionElevated Intraocular Pressure
Interventions
DRUG

ALZ-1101

ALZ-1101 Ophthalmic Solution

DRUG

Latanoprost

Latanoprost 0.005% Ophthalmic Solution

Trial Locations (1)

Unknown

Morrow

Sponsors
All Listed Sponsors
lead

Alleanza Pharmaceuticals, Inc.

INDUSTRY

NCT01896180 - Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost | Biotech Hunter | Biotech Hunter